These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3106230)

  • 1. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].
    Pennington JE; Pier GB
    Infection; 1987; 15(1):56-9. PubMed ID: 3106230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].
    Pennington JE; Pier GB
    Infection; 1987; 15 Suppl 2():S47-50. PubMed ID: 3112020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent experience with Pseudomonas aeruginosa immune globulin for the treatment of experimental pneumonia.
    Pennington JE
    J Hosp Infect; 1988 Aug; 12 Suppl D():55-60. PubMed ID: 2902130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host.
    Pennington JE; Small GJ
    J Infect Dis; 1987 May; 155(5):973-8. PubMed ID: 3104484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
    Pennington JE; Pier GB; Sadoff JC; Small GJ
    Rev Infect Dis; 1986; 8 Suppl 4():S426-33. PubMed ID: 2944209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of gram-negative and gram-positive infections using 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection using intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
    Collins MS; Hector RF; Roby RE; Edwards AA; Ladehoff DK; Dorsey JH
    Infection; 1987; 15(1):60-8. PubMed ID: 3570485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
    Collins MS; Hector RF; Roby RE; Edwards AA; Ladehoff DK; Dorsey JH
    Infection; 1987; 15 Suppl 2():S51-9. PubMed ID: 3112021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic strategies for Pseudomonas aeruginosa pneumonia in the myelosuppressed host.
    Pennington JE
    Antibiot Chemother (1971); 1987; 39():51-9. PubMed ID: 3118791
    [No Abstract]   [Full Text] [Related]  

  • 9. Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia.
    Pennington JE; Small GJ; Lostrom ME; Pier GB
    Infect Immun; 1986 Oct; 54(1):239-44. PubMed ID: 3093385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Passive immunotherapy for treatment of endobronchitis in cystic fibrosis].
    Moss RB
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():42-6; discussion 47. PubMed ID: 8499750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental pneumonia due to Pseudomonas aeruginosa in leukopenic dogs: prolongation of survival by combined treatment with passive antibody to Pseudomonas and granulocyte transfusions.
    Kazmierowski JA; Reynolds HY; Kauffman JC; Durbin WA; Graw RG; Devlin HB
    J Infect Dis; 1977 Mar; 135(3):438-46. PubMed ID: 403242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of Pseudomonas immunoglobulin in artificially respirated patients at an interdisciplinary surgical intensive care unit].
    Class I; Junginger W; Klöss T
    Infection; 1987; 15(1):76-9. PubMed ID: 3106233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of pseudomonas immunoglobulin. Indications and results].
    Werdan K; Melnitzki S; Pilz G; Reuschel-Janetschek E
    Anasth Intensivther Notfallmed; 1989 Jun; 24(3):153-61. PubMed ID: 2504071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host defense mechanisms against pneumonia due to Pseudomonas aeruginosa.
    Pennington JE; Ehrie MG; Hickey WF
    Rev Infect Dis; 1984; 6 Suppl 3():S657-66. PubMed ID: 6443767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic and protective properties of a murine lipopolysaccharide-specific monoclonal antibody in experimental Pseudomonas aeruginosa pneumonia in mice.
    Oishi K; Sonoda F; Miwa H; Tanaka H; Watanabe K; Matsumoto K; Pollack M
    Microbiol Immunol; 1991; 35(12):1131-41. PubMed ID: 1808464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary clearance of Pseudomonas aeruginosa in neutropenic mice. Effects of systemic immunization.
    Dunn MM; Kamp DW
    Am Rev Respir Dis; 1987 Jun; 135(6):1294-9. PubMed ID: 3109290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences with a Pseudomonas immunoglobulin in artificially respirated patients with Pseudomonas pneumonia at a surgical intensive care unit].
    Böhm D
    Infection; 1987; 15(1):73-5. PubMed ID: 3106232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models.
    Ahmadi H; Behrouz B; Irajian G; Amirmozafari N; Naghavi S
    Biologicals; 2017 Mar; 46():29-37. PubMed ID: 28065582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS; Roby RE
    Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental Pseudomonas aeruginosa pneumonia with a human IgM monoclonal antibody.
    Hector RF; Collins MS; Pennington JE
    J Infect Dis; 1989 Sep; 160(3):483-9. PubMed ID: 2760499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.